Vasoplegic Syndrome Clinical Trial
Official title:
Weaning of Norepinephrine Guided by the Dynamic Arterial Compliance in Cardiac Surgery Post Operative.
After cardiac surgery, vasoplegic syndrome is a hemodynamic state characterized by profound hypotension associated with a decrease in systemic vascular resistance. The care of this disease is based on the intravenous administration of a vasopressor, usually norepinephrine. During the recovery phase, weaning of norepinephrine, is an important step in which any lack of preload (blood volume) initial or secondary can be, and increase tissue malperfusion.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04440085 -
RaGuS Trial by Postoperative Patients
|
Phase 4 | |
| Recruiting |
NCT04054999 -
Methylene Blue vs Cyanokit for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
|
Phase 4 | |
| Completed |
NCT03333278 -
The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial
|
Phase 2 | |
| Completed |
NCT02675374 -
Hemodynamic Instability Prevented With Polaramine® Infusion Before Extracorporeal Circulation
|
Phase 3 | |
| Recruiting |
NCT05568160 -
Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation
|
Phase 3 | |
| Completed |
NCT06160219 -
Prophylactic Use of Hydroxycobolamin in Vasoplegic Syndrome in Adult Patients Undergoing Cardiopulmonary Bypass
|
Phase 2/Phase 3 | |
| Completed |
NCT05354193 -
Analysis of miRNAs Expression in Vasoplegic Syndrome After On-pump Coronary Artery Bypass Surgery
|
||
| Terminated |
NCT03735316 -
Vitamin B12a Vasoplegic Syndrome
|
Phase 2 |